Masters Degree in Natural or Agricultural Sciences / MVSc or bachelors degree in Engineering or Technology or Medicine from a recognized University or equivalent.
Candidates must have M.Sc. in Biochemistry, clinical Biochemistry, biotechnology / Life Sciences from a recognized university. Candidate must have submitted the PhD thesis.
Applications are invited for Second Semester admission to the PhD program (Full time and/or Part time)
starting January 2026 in Pilani, Goa and Hyderabad campuses of BITS Pilani
M. E. / M.Tech. / M.Pharm. / MSc. / MBA degree or equivalent. Experience in Total Quality Management / Global Business Excellence models with Maturity assessment and transformation programs experience.
Hetero is one of worlds leading producers of key Active Pharmaceutical Ingredients and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector.
A Bachelors degree in Pharmacy, Pharmaceutical Sciences, or a related field; advanced degree in Pharmaceutical Sciences or Regulatory Affairs is advantageous
Having Injectable Experience of Shop floor supervising activities like filtration, Filling, Sealing, Stoppering, Garment Washing, Vial Washing, Autoclave, Suspensions, Lyophilizes. Operations and Training and QMS.
MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has Fifteen API and Six finished dosage facilities established across India & USA.
Perform literature search, laboratory trials for formulation development and process optimization studies of Oral solids and Liquids formulations. Stability data, characterization data generation complying to drug regulatory & quality requirements.
A new Advocacy Paper, developed by leading nephrology experts of the country, outlines a roadmap to scale peritoneal dialysis - a simple, home-based treatment for kidney failure across India, ensuring equitable access to treatment for kidney failure, especially for rural and marginalised communities.
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt Lake City finds.
Zydus Lifesciences Limited has received approval from the National Medical Products Administration (NMPA), China for Venlafaxine Extended-Release (ER) Capsules, 75 mg and 150 mg.